Recently, we described cyclopeptide opioid agonists containing the D-Trp-Phe sequence. To expand the scope of this atypical pharmacophore, we tested the activity profiles of the linear peptides Ac-Xaa-Phe-Yaa (Xaa = L/D-Trp, D-His/Lys/ Arg; Yaa = H, GlyNH2). Ac-D-Trp-PheNH2 appeared to be the minimal binding sequence, while Ac-D-Trp-Phe-GlyNH2 emerged as the first noncationizable short peptide (partial) agonist with high μ-opioid receptor affinity and selectivity. Conformational analysis suggested that 5 adopts in solution a β-turn conformation
Herein we propose the d-Trp-Phe sequence within an inverse type II b-turn as a new kind of pharmacop...
The study reports the solid-phase synthesis and biological evaluation of a series of new side chain-...
d-Pen<sup>2</sup>,d-Pen<sup>5</sup> enkephalin (DPDPE) is one of the most selective synthetic peptid...
Recently, we described cyclopeptide opioid agonists containing the D-Trp-Phe sequence. To expand the...
Recently, we described cyclopeptide opioid agonists containing the d-Trp-Phe sequence. To expand the...
Recently, we described cyclopeptide opioid agonists containing the D-Trp-Phe sequence. To expand the...
none6In the last few years we discovered and investigated novel cyclic opioid peptides, c[Tyr-Xaa-D...
The study reports on a series of novel cyclopeptides based on the structure Tyr-[D-Lys-Phe-Phe-Asp]N...
In 2002 Saito isolated from the fungus Ctenomyces serratus the novel KOR antagonist CJ-15,208 (1), c...
Recently, the tryptophan-containing noncationizable opioid peptides emerged with atypical structure ...
none7An ultimate and general model describing the interaction between opioid ligands and mu-opioid r...
none3Despite substantial efforts by the pharmaceutical industry over the last decades, there has bee...
Recently, the tryptophan-containing noncationizable opioid peptides emerged with atypical structure ...
The development of the prototype synthetic δ-opioid receptor antagonist peptides TIPP [(H-Tyr-Tic-Ph...
Herein we propose the d-Trp-Phe sequence within an inverse type II b-turn as a new kind of pharmacop...
The study reports the solid-phase synthesis and biological evaluation of a series of new side chain-...
d-Pen<sup>2</sup>,d-Pen<sup>5</sup> enkephalin (DPDPE) is one of the most selective synthetic peptid...
Recently, we described cyclopeptide opioid agonists containing the D-Trp-Phe sequence. To expand the...
Recently, we described cyclopeptide opioid agonists containing the d-Trp-Phe sequence. To expand the...
Recently, we described cyclopeptide opioid agonists containing the D-Trp-Phe sequence. To expand the...
none6In the last few years we discovered and investigated novel cyclic opioid peptides, c[Tyr-Xaa-D...
The study reports on a series of novel cyclopeptides based on the structure Tyr-[D-Lys-Phe-Phe-Asp]N...
In 2002 Saito isolated from the fungus Ctenomyces serratus the novel KOR antagonist CJ-15,208 (1), c...
Recently, the tryptophan-containing noncationizable opioid peptides emerged with atypical structure ...
none7An ultimate and general model describing the interaction between opioid ligands and mu-opioid r...
none3Despite substantial efforts by the pharmaceutical industry over the last decades, there has bee...
Recently, the tryptophan-containing noncationizable opioid peptides emerged with atypical structure ...
The development of the prototype synthetic δ-opioid receptor antagonist peptides TIPP [(H-Tyr-Tic-Ph...
Herein we propose the d-Trp-Phe sequence within an inverse type II b-turn as a new kind of pharmacop...
The study reports the solid-phase synthesis and biological evaluation of a series of new side chain-...
d-Pen<sup>2</sup>,d-Pen<sup>5</sup> enkephalin (DPDPE) is one of the most selective synthetic peptid...